Datasets:
ncbi
/

Languages:
English
Multilinguality:
monolingual
Size Categories:
1K<n<10K
Language Creators:
expert-generated
Annotations Creators:
expert-generated
Source Datasets:
original
License:
system HF staff commited on
Commit
7f72f85
1 Parent(s): 7512d39

Update files from the datasets library (from 1.15.0)

Browse files

Release notes: https://github.com/huggingface/datasets/releases/tag/1.15.0

Files changed (1) hide show
  1. README.md +100 -44
README.md CHANGED
@@ -18,59 +18,73 @@ task_categories:
18
  task_ids:
19
  - named-entity-recognition
20
  paperswithcode_id: ncbi-disease-1
 
21
  ---
22
 
23
- # Dataset Card for [Dataset Name]
24
 
25
  ## Table of Contents
26
- - [Dataset Description](#dataset-description)
27
- - [Dataset Summary](#dataset-summary)
28
- - [Supported Tasks and Leaderboards](#supported-tasks-and-leaderboards)
29
- - [Languages](#languages)
30
- - [Dataset Structure](#dataset-structure)
31
- - [Data Instances](#data-instances)
32
- - [Data Fields](#data-fields)
33
- - [Data Splits](#data-splits)
34
- - [Dataset Creation](#dataset-creation)
35
- - [Curation Rationale](#curation-rationale)
36
- - [Source Data](#source-data)
37
- - [Annotations](#annotations)
38
- - [Personal and Sensitive Information](#personal-and-sensitive-information)
39
- - [Considerations for Using the Data](#considerations-for-using-the-data)
40
- - [Social Impact of Dataset](#social-impact-of-dataset)
41
- - [Discussion of Biases](#discussion-of-biases)
42
- - [Other Known Limitations](#other-known-limitations)
43
- - [Additional Information](#additional-information)
44
- - [Dataset Curators](#dataset-curators)
45
- - [Licensing Information](#licensing-information)
46
- - [Citation Information](#citation-information)
47
- - [Contributions](#contributions)
 
 
 
 
 
 
48
 
49
  ## Dataset Description
50
 
51
- - **Homepage:** [NCBI](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951655/)
52
  - **Repository:** [Github](https://github.com/spyysalo/ncbi-disease)
53
- - **Paper:**
54
- - **Leaderboard:**
55
- - **Point of Contact:**
56
 
57
  ### Dataset Summary
58
 
59
- [More Information Needed]
60
 
61
  ### Supported Tasks and Leaderboards
62
 
63
- [More Information Needed]
64
 
65
  ### Languages
66
 
67
- [More Information Needed]
68
 
69
  ## Dataset Structure
70
 
71
  ### Data Instances
72
 
73
- [More Information Needed]
 
 
 
 
 
 
 
74
 
75
  ### Data Fields
76
 
@@ -80,65 +94,107 @@ paperswithcode_id: ncbi-disease-1
80
 
81
  ### Data Splits
82
 
83
- [More Information Needed]
84
 
85
  ## Dataset Creation
86
 
87
  ### Curation Rationale
88
 
89
- [More Information Needed]
90
 
91
  ### Source Data
92
 
93
  #### Initial Data Collection and Normalization
94
 
95
- [More Information Needed]
96
 
97
  #### Who are the source language producers?
98
 
99
- [More Information Needed]
100
 
101
  ### Annotations
102
 
103
  #### Annotation process
104
 
105
- [More Information Needed]
106
 
107
  #### Who are the annotators?
108
 
109
- [More Information Needed]
110
 
111
  ### Personal and Sensitive Information
112
 
113
- [More Information Needed]
114
 
115
  ## Considerations for Using the Data
116
 
117
  ### Social Impact of Dataset
118
 
119
- [More Information Needed]
120
 
121
  ### Discussion of Biases
122
 
123
- [More Information Needed]
124
 
125
  ### Other Known Limitations
126
 
127
- [More Information Needed]
 
 
 
 
128
 
129
  ## Additional Information
130
 
131
  ### Dataset Curators
132
 
133
- [More Information Needed]
134
 
135
  ### Licensing Information
136
 
137
- [More Information Needed]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
138
 
139
  ### Citation Information
140
 
141
- [More Information Needed]
 
 
 
 
 
 
 
 
 
 
142
 
143
  ### Contributions
144
 
 
18
  task_ids:
19
  - named-entity-recognition
20
  paperswithcode_id: ncbi-disease-1
21
+ pretty_name: NCBI Disease
22
  ---
23
 
24
+ # Dataset Card for NCBI Disease
25
 
26
  ## Table of Contents
27
+ - [Dataset Card for NCBI Disease](#dataset-card-for-ncbi-disease)
28
+ - [Table of Contents](#table-of-contents)
29
+ - [Dataset Description](#dataset-description)
30
+ - [Dataset Summary](#dataset-summary)
31
+ - [Supported Tasks and Leaderboards](#supported-tasks-and-leaderboards)
32
+ - [Languages](#languages)
33
+ - [Dataset Structure](#dataset-structure)
34
+ - [Data Instances](#data-instances)
35
+ - [Data Fields](#data-fields)
36
+ - [Data Splits](#data-splits)
37
+ - [Dataset Creation](#dataset-creation)
38
+ - [Curation Rationale](#curation-rationale)
39
+ - [Source Data](#source-data)
40
+ - [Initial Data Collection and Normalization](#initial-data-collection-and-normalization)
41
+ - [Who are the source language producers?](#who-are-the-source-language-producers)
42
+ - [Annotations](#annotations)
43
+ - [Annotation process](#annotation-process)
44
+ - [Who are the annotators?](#who-are-the-annotators)
45
+ - [Personal and Sensitive Information](#personal-and-sensitive-information)
46
+ - [Considerations for Using the Data](#considerations-for-using-the-data)
47
+ - [Social Impact of Dataset](#social-impact-of-dataset)
48
+ - [Discussion of Biases](#discussion-of-biases)
49
+ - [Other Known Limitations](#other-known-limitations)
50
+ - [Additional Information](#additional-information)
51
+ - [Dataset Curators](#dataset-curators)
52
+ - [Licensing Information](#licensing-information)
53
+ - [Citation Information](#citation-information)
54
+ - [Contributions](#contributions)
55
 
56
  ## Dataset Description
57
 
58
+ - **Homepage:** [NCBI](https://www.ncbi.nlm.nih.gov/research/bionlp/Data/disease)
59
  - **Repository:** [Github](https://github.com/spyysalo/ncbi-disease)
60
+ - **Paper:** [NCBI disease corpus: A resource for disease name recognition and concept normalization](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951655)
61
+ - **Leaderboard:** [Named Entity Recognition on NCBI-disease](https://paperswithcode.com/sota/named-entity-recognition-ner-on-ncbi-disease)
62
+ - **Point of Contact:** zhiyong.lu@nih.gov
63
 
64
  ### Dataset Summary
65
 
66
+ This dataset contains the disease name and concept annotations of the NCBI disease corpus, a collection of 793 PubMed abstracts fully annotated at the mention and concept level to serve as a research resource for the biomedical natural language processing community.
67
 
68
  ### Supported Tasks and Leaderboards
69
 
70
+ Named Entity Recognition: [Leaderboard](https://paperswithcode.com/sota/named-entity-recognition-ner-on-ncbi-disease)
71
 
72
  ### Languages
73
 
74
+ The text in the dataset is in English. The associated BCP-47 code is `en`.
75
 
76
  ## Dataset Structure
77
 
78
  ### Data Instances
79
 
80
+ Instances of the dataset contain an array of `tokens`, `ner_tags` and an `id`. An example of an instance of the dataset:
81
+ ```
82
+ {
83
+ 'tokens': ['Identification', 'of', 'APC2', ',', 'a', 'homologue', 'of', 'the', 'adenomatous', 'polyposis', 'coli', 'tumour', 'suppressor', '.'],
84
+ 'ner_tags': [0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0],
85
+ 'id': '0'
86
+ }
87
+ ```
88
 
89
  ### Data Fields
90
 
 
94
 
95
  ### Data Splits
96
 
97
+ The data is split into a train (5433 instances), validation (924 instances) and test set (941 instances).
98
 
99
  ## Dataset Creation
100
 
101
  ### Curation Rationale
102
 
103
+ The goal of the dataset consists on improving the state-of-the-art in disease name recognition and normalization research, by providing a high-quality gold standard thus enabling the development of machine-learning based approaches for such tasks.
104
 
105
  ### Source Data
106
 
107
  #### Initial Data Collection and Normalization
108
 
109
+ The dataset consists on abstracts extracted from PubMed.
110
 
111
  #### Who are the source language producers?
112
 
113
+ The source language producers are the authors of publication abstracts hosted in PubMed.
114
 
115
  ### Annotations
116
 
117
  #### Annotation process
118
 
119
+ Each PubMed abstract was manually annotated by two annotators with disease mentions and their corresponding concepts in Medical Subject Headings (MeSH®) or Online Mendelian Inheritance in Man (OMIM®). Manual curation was performed using PubTator, which allowed the use of pre-annotations as a pre-step to manual annotations. Fourteen annotators were randomly paired and differing annotations were discussed for reaching a consensus in two annotation phases. Finally, all results were checked against annotations of the rest of the corpus to assure corpus-wide consistency.
120
 
121
  #### Who are the annotators?
122
 
123
+ The annotator group consisted of 14 people with backgrounds in biomedical informatics research and experience in biomedical text corpus annotation.
124
 
125
  ### Personal and Sensitive Information
126
 
127
+ [N/A]
128
 
129
  ## Considerations for Using the Data
130
 
131
  ### Social Impact of Dataset
132
 
133
+ Information encoded in natural language in biomedical literature publications is only useful if efficient and reliable ways of accessing and analyzing that information are available. Natural language processing and text mining tools are therefore essential for extracting valuable information. This dataset provides an annotated corpora that can be used to develop highly effective tools to automatically detect central biomedical concepts such as diseases.
134
 
135
  ### Discussion of Biases
136
 
137
+ To avoid annotator bias, pairs of annotators were chosen randomly for each set, so that each pair of annotators overlapped for at most two sets.
138
 
139
  ### Other Known Limitations
140
 
141
+ A handful of disease concepts were discovered that were not included in MEDIC. For those, we decided to include the appropriate OMIM identifiers.
142
+
143
+ In addition, certain disease mentions were found to not be easily represented using the standard categorizations.
144
+
145
+ Also, each PMID document was pre-annotated using the Inference Method developed for disease name normalization, which properly handles abbreviation recognition, robust string matching, etc. As such, human annotators were given the pre-annotated documents as a starting point and allowed to see each pre-annotation with a computed confidence.
146
 
147
  ## Additional Information
148
 
149
  ### Dataset Curators
150
 
151
+ Rezarta Islamaj Doğan, Robert Leaman, Zhiyong Lu
152
 
153
  ### Licensing Information
154
 
155
+ ```
156
+ PUBLIC DOMAIN NOTICE
157
+
158
+ This work is a "United States Government Work" under the terms of the
159
+ United States Copyright Act. It was written as part of the authors'
160
+ official duties as a United States Government employee and thus cannot
161
+ be copyrighted within the United States. The data is freely available
162
+ to the public for use. The National Library of Medicine and the
163
+ U.S. Government have not placed any restriction on its use or
164
+ reproduction.
165
+
166
+ Although all reasonable efforts have been taken to ensure the accuracy
167
+ and reliability of the data and its source code, the NLM and the
168
+ U.S. Government do not and cannot warrant the performance or results
169
+ that may be obtained by using it. The NLM and the U.S. Government
170
+ disclaim all warranties, express or implied, including warranties of
171
+ performance, merchantability or fitness for any particular purpose.
172
+
173
+ Please cite the authors in any work or product based on this material:
174
+
175
+ An improved corpus of disease mentions in PubMed citations
176
+ http://aclweb.org/anthology-new/W/W12/W12-2411.pdf
177
+
178
+ NCBI Disease Corpus: A Resource for Disease Name Recognition and
179
+ Normalization http://www.ncbi.nlm.nih.gov/pubmed/24393765
180
+
181
+ Disease Name Normalization with Pairwise Learning to Rank
182
+ http://www.ncbi.nlm.nih.gov/pubmed/23969135
183
+ ```
184
 
185
  ### Citation Information
186
 
187
+ ```
188
+ @article{dougan2014ncbi,
189
+ title={NCBI disease corpus: a resource for disease name recognition and concept normalization},
190
+ author={Do{\u{g}}an, Rezarta Islamaj and Leaman, Robert and Lu, Zhiyong},
191
+ journal={Journal of biomedical informatics},
192
+ volume={47},
193
+ pages={1--10},
194
+ year={2014},
195
+ publisher={Elsevier}
196
+ }
197
+ ```
198
 
199
  ### Contributions
200